-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 16, Chutian Technology replied to investors on the investor interaction platform that the Chutian Siyoute Shanghai factory is currently under construction and is expected to be put into production within the year
.
Chutian Siyoute Shanghai Factory is a holding company established by Chutian Technology
.
On December 31, 2021, the research activity announcement released by Trutian Technology stated that in the field of disposable consumables, Trutian Technology has established Siyoute, and Trutian Siyoute has established a subsidiary in Shanghai and is building 6 Lingang in Shanghai.
The factory building of about 1,000 square meters can achieve a production capacity of 200 million yuan after completion, which will be used for the development and production of disposable bioreactors, liquid dispensing bags, liquid storage bags and their membrane materials
.
It is planned to complete product verification in the first quarter of this year, and after the verification is passed, it can be sold and promoted in the market
.
In the future, a production capacity of 800 million to 1 billion will be planned and constructed in Ningxiang
.
Disposable consumables are widely used in the biomedical industry and have great prospects
.
In recent years, with the intensification of aging and the support of a series of favorable policies, China's biopharmaceutical industry has developed rapidly and the market size has continued to expand
.
In 2020, the scale of China's biopharmaceutical market will be about 400 billion yuan
.
According to the Frost & Sullivan report, it is estimated that by 2024, the scale of China's biopharmaceutical market will exceed US$100 billion
.
Compared with stainless steel tanks, market participants believe that disposable consumables are more flexible, have low investment costs, and have high production efficiency, which can accelerate the commercialization process of biopharmaceutical companies, so there is a huge market space
.
It is understood that in the field of biopharmaceuticals, including the production of pre-clinical and clinical samples, disposable filters, disposable mixers, disposable bioreactors and other equipment have appeared
.
BioPlan says 85% of preclinical and clinical manufacturing is currently single-use systems
.
Expansion of single-use systems will involve the adoption of ≥ 2,000 single-use bioreactor-based commercial lines, including horizontal scaling with multiple bioreactors or the entire line running in parallel, rather than traditional large stainless steel bioreactors and lines Scale up
.
Domestic enterprises that deploy disposable consumables have attracted market attention in the past two years
.
Chutian Technology previously stated in an announcement that the company has deployed disposable bioreactors, disposable liquid dispensing systems, ultrafiltration chromatography purification, stainless steel reactors and fillers
.
Now, with the upcoming production of the Chutian Siyoute plant, it will provide guarantee for the production capacity of disposable bioreactors, liquid dispensing bags, liquid storage bags and their membrane materials
.
Tofflon is also one of the main R&D and production enterprises of single-use products in China.
The company is committed to the design, production and sales of various process consumables for one-time use in the biopharmaceutical process, including full-size single-use sterile bags, disposable Freeze-dried trays, disposable sterile filter media,
etc.
Since 2020, Tofflon has provided effective support for the rapid production of vaccines
.
The upstream and downstream process consumables developed and produced by the company in the biopharmaceutical industry can meet the complex process requirements of vaccine production, and provide various consumables from 5L to 3000L, providing a complete one-time solution for the vaccine and biopharmaceutical industries
.
According to reports, in the general vaccine production process, single-use consumables can be used in the preparation of culture medium, the preparation of downstream buffers, the preparation of preparations, the preparation of excipients and adjuvants, and the preparation of single-use preparation filling lines.
design
.
Single-use technology can be used throughout the upstream to downstream of the vaccine, including sterile connection and disconnection, which can be implemented faster, more flexible, and safer through single-use technology
.
Taking the liquid storage as an example, if the single-use technology is used, the construction can be completed within 3 months, and the existing equipment can be flexibly connected.
The fully enclosed system can effectively reduce the risk of virus leakage and reduce the threat of production personnel.
Improved biosecurity
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
Chutian Siyoute Shanghai Factory is a holding company established by Chutian Technology
.
On December 31, 2021, the research activity announcement released by Trutian Technology stated that in the field of disposable consumables, Trutian Technology has established Siyoute, and Trutian Siyoute has established a subsidiary in Shanghai and is building 6 Lingang in Shanghai.
The factory building of about 1,000 square meters can achieve a production capacity of 200 million yuan after completion, which will be used for the development and production of disposable bioreactors, liquid dispensing bags, liquid storage bags and their membrane materials
.
It is planned to complete product verification in the first quarter of this year, and after the verification is passed, it can be sold and promoted in the market
.
In the future, a production capacity of 800 million to 1 billion will be planned and constructed in Ningxiang
.
Disposable consumables are widely used in the biomedical industry and have great prospects
.
In recent years, with the intensification of aging and the support of a series of favorable policies, China's biopharmaceutical industry has developed rapidly and the market size has continued to expand
.
In 2020, the scale of China's biopharmaceutical market will be about 400 billion yuan
.
According to the Frost & Sullivan report, it is estimated that by 2024, the scale of China's biopharmaceutical market will exceed US$100 billion
.
Compared with stainless steel tanks, market participants believe that disposable consumables are more flexible, have low investment costs, and have high production efficiency, which can accelerate the commercialization process of biopharmaceutical companies, so there is a huge market space
.
It is understood that in the field of biopharmaceuticals, including the production of pre-clinical and clinical samples, disposable filters, disposable mixers, disposable bioreactors and other equipment have appeared
.
BioPlan says 85% of preclinical and clinical manufacturing is currently single-use systems
.
Expansion of single-use systems will involve the adoption of ≥ 2,000 single-use bioreactor-based commercial lines, including horizontal scaling with multiple bioreactors or the entire line running in parallel, rather than traditional large stainless steel bioreactors and lines Scale up
.
Domestic enterprises that deploy disposable consumables have attracted market attention in the past two years
.
Chutian Technology previously stated in an announcement that the company has deployed disposable bioreactors, disposable liquid dispensing systems, ultrafiltration chromatography purification, stainless steel reactors and fillers
.
Now, with the upcoming production of the Chutian Siyoute plant, it will provide guarantee for the production capacity of disposable bioreactors, liquid dispensing bags, liquid storage bags and their membrane materials
.
Tofflon is also one of the main R&D and production enterprises of single-use products in China.
The company is committed to the design, production and sales of various process consumables for one-time use in the biopharmaceutical process, including full-size single-use sterile bags, disposable Freeze-dried trays, disposable sterile filter media,
etc.
Since 2020, Tofflon has provided effective support for the rapid production of vaccines
.
The upstream and downstream process consumables developed and produced by the company in the biopharmaceutical industry can meet the complex process requirements of vaccine production, and provide various consumables from 5L to 3000L, providing a complete one-time solution for the vaccine and biopharmaceutical industries
.
According to reports, in the general vaccine production process, single-use consumables can be used in the preparation of culture medium, the preparation of downstream buffers, the preparation of preparations, the preparation of excipients and adjuvants, and the preparation of single-use preparation filling lines.
design
.
Single-use technology can be used throughout the upstream to downstream of the vaccine, including sterile connection and disconnection, which can be implemented faster, more flexible, and safer through single-use technology
.
Taking the liquid storage as an example, if the single-use technology is used, the construction can be completed within 3 months, and the existing equipment can be flexibly connected.
The fully enclosed system can effectively reduce the risk of virus leakage and reduce the threat of production personnel.
Improved biosecurity
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
